» Articles » PMID: 23150753

The Regulation of Multiple P53 Stress Responses is Mediated Through MDM2

Overview
Journal Genes Cancer
Specialty Oncology
Date 2012 Nov 15
PMID 23150753
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

The MDM2 oncogene is a key negative regulator of the p53 tumor suppressor protein. MDM2 and p53 form an autoregulatory feedback loop to tightly control the proper cellular responses to various stress signals in order to prevent mutations and tumor formation. The levels and function of the MDM2 protein, an E3 ubiquitin ligase, are regulated by a wide variety of extracellular and intracellular stress signals through distinct signaling pathways and mechanisms. These signals regulate the E3 ubiquitin ligase activity of MDM2, the ability of MDM2 to interact with p53 and a number of other proteins, and the cellular localization of MDM2, which in turn impact significantly upon p53 function. This review provides an overview of the regulation of MDM2 activities by the signals and factors that regulate the MDM2 protein, including genotoxic stress signals, oncogenic activation, cell cycle transition, ribosomal stress, chronic stress, neurohormones, and microRNAs. Disruption of the proper regulation of the MDM2-p53 negative feedback loop impacts significantly upon the frequency of tumorigenesis in a host. A better understanding of the complex regulation of MDM2 and its impact upon p53 function in cells under different conditions will help to develop novel and more effective strategies for cancer therapy and prevention.

Citing Articles

Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma.

Barakat A, El-Senduny F, Islam M, Al-Majid A, Elshaier Y, Mazyed E Pharmaceutics. 2025; 17(1).

PMID: 39861743 PMC: 11768502. DOI: 10.3390/pharmaceutics17010093.


Modulating the p53-MDM2 pathway: the therapeutic potential of natural compounds in cancer treatment.

Ramli I, Cheriet T, Posadino A, Giordo R, Fenu G, Chukwuemeka Nwachukwu K EXCLI J. 2025; 23:1397-1439.

PMID: 39764218 PMC: 11701300. DOI: 10.17179/excli2024-7791.


PWP1 transcriptionally regulates p53, modulating apoptosis and cell cycle to promote gastric cancer progression.

Jiang M, Wang S, Ji J, Baral S, Sun Q, Wang Y Apoptosis. 2024; .

PMID: 39720977 DOI: 10.1007/s10495-024-02049-x.


Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53.

Gong L, Xu D, Ni K, Li J, Mao W, Zhang B Adv Sci (Weinh). 2024; 12(4):e2402258.

PMID: 39629919 PMC: 11789598. DOI: 10.1002/advs.202402258.


A Barth Syndrome Patient-Derived Point Mutation in Drives Progressive Cardiomyopathy in Mice.

Snider P, Sierra Potchanant E, Sun Z, Edwards D, Chan K, Matias C Int J Mol Sci. 2024; 25(15).

PMID: 39125771 PMC: 11311365. DOI: 10.3390/ijms25158201.


References
1.
Thut C, Goodrich J, Tjian R . Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev. 1997; 11(15):1974-86. PMC: 316412. DOI: 10.1101/gad.11.15.1974. View

2.
Sharp D, Kratowicz S, Sank M, GEORGE D . Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J Biol Chem. 1999; 274(53):38189-96. DOI: 10.1074/jbc.274.53.38189. View

3.
Donehower L . Using mice to examine p53 functions in cancer, aging, and longevity. Cold Spring Harb Perspect Biol. 2010; 1(6):a001081. PMC: 2882127. DOI: 10.1101/cshperspect.a001081. View

4.
Pillai R, Bhattacharyya S, Filipowicz W . Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol. 2007; 17(3):118-26. DOI: 10.1016/j.tcb.2006.12.007. View

5.
Maya R, Balass M, Kim S, Shkedy D, Leal J, Shifman O . ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 2001; 15(9):1067-77. PMC: 312683. DOI: 10.1101/gad.886901. View